Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: zakaran who wrote (1129)	12/14/2000 4:38:58 PM
From: Stephen Krupa	Respond to of 1321

Today's volume was 13,000,000 plus vs 1m plus. Could this be sales only or are these a bunchof shorts? Steve

To: zakaran who wrote (1129)	12/14/2000 6:55:05 PM
From: Alan Gallaspy	Respond to of 1321

Anything that even remotely resembles bad news in this bearish environment will cause a company like QLT to be drawn and quartered. The story with this company is intact, Visudyne is still a vast improvement over existing treatments, and the people who administer insurance and medical care will ultimately pay rather than let 1000's go blind.

To: zakaran who wrote (1129)	12/14/2000 9:09:13 PM
From: Zeev Hed	Read Replies (1) \| Respond to of 1321

Zakaran, QLTI is an excellent company with an excellent long term outlook. If you have a very long time horizon, the prices around here are probably pretty "cheap". If you do not have the stomach for seeing your investment halved in six months, you may want to wait. It is my personal opinion (based on general market outlook and the specific technical picture of QLTI) that a breach of today's low ($24) would probably lead to prices in the mid teens by March or April of next year. A possible tactic would be to try and buy in the $25 to $27 area with a mental stop at $24. If the stop is hit, you may want to wait to see if indeed it ends up in the mid teens before committing again. JMHO Zeev